With this being the company’s first redaction project, Synchrogenix provided expertise and guidance to team members on redaction requirements. Synchrogenix facilitated redaction rule definitions; provided assistance in planning for their Health Canada Process Initiation Meeting; and guided the client internal team on identification and review of patient sensitive and company business confidential information.

Emerging Biotech selects Synchrogenix Body Content 1

Thank you so much for providing all the documents required for the XXX NDS PRCI project, including the proposed redaction documents for PI and CBI, anonymization report and CBI control sheet.

Regulatory Director Global biotechnology company

Health Canada’s objective is to make anonymized clinical information in drug submissions and medical device applications publicly available for non-commercial purposes following the completion of Health Canada’s regulatory review process, while adhering to Canada’s Privacy Act.

Emerging Biotech selects Synchrogenix Body Content 2


Powered by Translations.com GlobalLink OneLink Software